Stay updated with breaking news from Memory Disorder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- DelveInsight's Hepatic Encephalopathy Market report delivers an in-depth understanding of current treatment practices, emerging drugs, Hepatic...
/PRNewswire/ -- DelveInsight's Huntington's Disease Market Insights report provides a thorough understanding of current treatment practices, emerging drugs,...
![DelveInsight Business Research, LLP: Huntington's Disease Market Size Expected to Surge with a Significant CAGR of 22.5% in the 7MM During the Study Period [2018-30] - Vimarsana News](https://vimarsana.com/images/vimarsana-bigimage.jpg)
The untapped market of Huntington's Disease is anticipated to expand primarily because of the introduction of novel emerging therapies, rising prevalence and elderly population, increased R&D
/PRNewswire/ -- DelveInsight's Huntington's Disease Market Insights report provides a thorough understanding of current treatment practices, emerging drugs,...
Michigan Institute for Neurological Disorders first in country to administer new Alzheimer's drug Posted at 2:59 PM, Jun 16, 2021 and last updated 2021-06-16 14:59:21-04 (WXYZ) â The Michigan Institute for Neurological Disorders was the first in the country to administer the new FDA-approved Alzheimer's drug. Biogenâs Aduhelm (generic name of aducanumab), the first-ever disease modifying therapy for Mild Cognitive Impairment (MCI)/early Alzheimerâs disease. The patient IV began at 10:45 a.m. Wednesday morning and drug administration commenced at 10:46 a.m. The patient, a 68-y...